1. Home
  2. AMWD vs BLFS Comparison

AMWD vs BLFS Comparison

Compare AMWD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Woodmark Corporation

AMWD

American Woodmark Corporation

HOLD

Current Price

$38.69

Market Cap

566.8M

ML Signal

HOLD

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$24.01

Market Cap

923.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWD
BLFS
Founded
1980
1987
Country
United States
United States
Employees
7800
N/A
Industry
Forest Products
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
566.8M
923.5M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
AMWD
BLFS
Price
$38.69
$24.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$59.50
$32.00
AVG Volume (30 Days)
259.6K
429.0K
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.27
EPS
N/A
0.02
Revenue
$1,709,585,000.00
$96,214,000.00
Revenue This Year
N/A
$19.73
Revenue Next Year
N/A
$17.82
P/E Ratio
N/A
$1,235.25
Revenue Growth
N/A
16.97
52 Week Low
$33.29
$17.86
52 Week High
$72.16
$29.57

Technical Indicators

Market Signals
Indicator
AMWD
BLFS
Relative Strength Index (RSI) 48.02 62.58
Support Level $36.48 $23.74
Resistance Level $42.58 $26.55
Average True Range (ATR) 2.02 1.19
MACD 0.07 0.27
Stochastic Oscillator 58.11 77.08

Price Performance

Historical Comparison
AMWD
BLFS

About AMWD American Woodmark Corporation

American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: